ISSN: 2577-4379
Rheumatoid Arthritis Refractory to DMARDs: A Case Study
Authors:
Sakhawat F and Sadeeqa S*
In past few years there has been an enthusiastic progress in the field of rheumatoid arthritis pharmacotherapy but the presence of prognostic factors associated with unfavorable outcomes and the inappropriate and/or delayed initiation of DMARDsmay diminish the likelihood of achieving remission and/or increase the probability of refractoriness to treatment.
Keywords:
Rheumatoid arthritis; Unfavorable outcomes; Refractory patients; DMARDs; Biologics
